Q4 2024 Management View Udit Batra, CEO, highlighted high single-digit constant currency revenue growth and low teens adjusted EPS growth for Q4 2024. Sales in the Pharma segment, the largest market, ...
The Senate will vote Thursday on whether to put RFK Jr. in charge of health. It's unclear how he will impact biotech stocks.